AIF deficiency compromises oxidative phosphorylation.

Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J (2007) 11.72

Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev (2006) 3.31

Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev (2012) 2.76

Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab (2008) 2.72

Metabolic regulation by p53. J Mol Med (Berl) (2011) 2.26

Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol (2009) 2.24

Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol (2007) 2.22

Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal (2010) 2.11

Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol (2010) 2.01

Metabolic regulation by p53 family members. Cell Metab (2013) 2.00

Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature (2011) 1.98

Parthanatos, a messenger of death. Front Biosci (Landmark Ed) (2009) 1.84

Analysis of the assembly profiles for mitochondrial- and nuclear-DNA-encoded subunits into complex I. Mol Cell Biol (2007) 1.82

No death without life: vital functions of apoptotic effectors. Cell Death Differ (2008) 1.80

Caspase-independent cell death: leaving the set without the final cut. Oncogene (2008) 1.74

Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J (2007) 1.68

Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J (2006) 1.59

Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol (2005) 1.58

Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet (2008) 1.58

Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncol Lett (2012) 1.58

The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev (2009) 1.57

Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics (2010) 1.54

Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet (2010) 1.53

AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J (2010) 1.52

Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis. Mol Cell Biol (2006) 1.49

Human ind1, an iron-sulfur cluster assembly factor for respiratory complex I. Mol Cell Biol (2009) 1.46

BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells. Clin Cancer Res (2009) 1.45

Deletion of the mitochondrial flavoprotein apoptosis inducing factor (AIF) induces beta-cell apoptosis and impairs beta-cell mass. PLoS One (2009) 1.44

Apoptosis-Inducing-Factor-Dependent Mitochondrial Function Is Required for T Cell but Not B Cell Function. Immunity (2016) 1.40

Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet (2009) 1.39

Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal (2011) 1.37

Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta (2009) 1.31

Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. Am J Hum Genet (2012) 1.30

Mitochondria: a target for cancer therapy. Br J Pharmacol (2006) 1.29

Mitochondrial centrality in heart failure. Heart Fail Rev (2008) 1.28

3-Bromopyruvate: targets and outcomes. J Bioenerg Biomembr (2012) 1.27

Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin Cancer Biol (2008) 1.27

Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci U S A (2010) 1.26

Loss of Aif function causes cell death in the mouse embryo, but the temporal progression of patterning is normal. Proc Natl Acad Sci U S A (2006) 1.24

Cuts can kill: the roles of apoptotic nucleases in cell death and animal development. Chromosoma (2006) 1.22

Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration. Am J Pathol (2008) 1.20

Mitochondrial regulation of cell death. Cold Spring Harb Perspect Biol (2013) 1.19

Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria. Free Radic Biol Med (2009) 1.17

AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. EMBO J (2005) 1.17

Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling. J Mol Cell Cardiol (2009) 1.17

Mass estimation of native proteins by blue native electrophoresis: principles and practical hints. Mol Cell Proteomics (2010) 1.16

Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Sci (2011) 1.16

Proteomic analysis of the mitochondria from embryonic and postnatal rat brains reveals response to developmental changes in energy demands. J Proteomics (2014) 1.16

Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget (2011) 1.15

Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space. Antioxid Redox Signal (2010) 1.12

The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci (2013) 1.12

Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience (2006) 1.10

Mitochondrial respiratory complex I: structure, function and implication in human diseases. Curr Med Chem (2009) 1.08

Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix. Mol Cell Biol (2007) 1.08

Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br J Pharmacol (2012) 1.07

Non-apoptotic functions of apoptosis-regulatory proteins. EMBO Rep (2012) 1.06

Mitochondria and diabetes mellitus: untangling a conflictive relationship? J Inherit Metab Dis (2009) 1.06

Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress. Cell Health Cytoskelet (2012) 1.04

Redox-linked conformational dynamics in apoptosis-inducing factor. J Mol Biol (2009) 1.03

Apoptosis-inducing factor is a target for ubiquitination through interaction with XIAP. Mol Cell Biol (2007) 1.03

Early complex I assembly defects result in rapid turnover of the ND1 subunit. Hum Mol Genet (2012) 1.02

Mitochondrial disorders caused by mutations in respiratory chain assembly factors. Semin Fetal Neonatal Med (2011) 1.02

AIF, reactive oxygen species, and neurodegeneration: a "complex" problem. Neurochem Int (2012) 1.02

Insights into the composition and assembly of the membrane arm of plant complex I through analysis of subcomplexes in Arabidopsis mutant lines. J Biol Chem (2011) 1.01

Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics (2009) 0.98

The molecular archaeology of a mitochondrial death effector: AIF in Drosophila. Cell Death Differ (2008) 0.98

Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol (2011) 0.98

p53 and mitochondrial function in neurons. Biochim Biophys Acta (2014) 0.97

Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations. J Inherit Metab Dis (2010) 0.97

Eukaryotic complex I: functional diversity and experimental systems to unravel the assembly process. Mol Genet Genomics (2008) 0.97

The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS One (2008) 0.97

Deletion of PaAif2 and PaAmid2, two genes encoding mitochondrial AIF-like oxidoreductases of Podospora anserina, leads to increased stress tolerance and lifespan extension. Curr Genet (2010) 0.97

Response of caspase-independent apoptotic factors to high salt diet-induced heart failure. J Mol Cell Cardiol (2007) 0.93

Apoptosis in cardiovascular diseases: mechanism and clinical implications. Korean Circ J (2010) 0.93

Effect of methionine dietary supplementation on mitochondrial oxygen radical generation and oxidative DNA damage in rat liver and heart. J Bioenerg Biomembr (2009) 0.92

Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis. J Cell Biol (2012) 0.92

Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors. Antioxid Redox Signal (2012) 0.91

Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog Retin Eye Res (2013) 0.91

Loss of apoptosis-inducing factor critically affects MIA40 function. Cell Death Dis (2015) 0.90

The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem (2014) 0.90

Mitochondria in heart failure: the emerging role of mitochondrial dynamics. Heart Fail Rev (2013) 0.90

Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle (2012) 0.90

Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency. J Inherit Metab Dis (2010) 0.90

Role of the mitochondrion in programmed necrosis. Front Physiol (2010) 0.90

A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. J Bioenerg Biomembr (2007) 0.90

p53, aerobic metabolism, and cancer. Antioxid Redox Signal (2011) 0.90

p53 as an intervention target for cancer and aging. Pathobiol Aging Age Relat Dis (2013) 0.89

Increased resistance of complex I mutants to phytosphingosine-induced programmed cell death. J Biol Chem (2008) 0.88

Cytokine-induced tumor suppressors: a GRIM story. Cytokine (2010) 0.88

TIMMDC1/C3orf1 functions as a membrane-embedded mitochondrial complex I assembly factor through association with the MCIA complex. Mol Cell Biol (2013) 0.88

Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy. Proc Natl Acad Sci U S A (2012) 0.88

Molecular basis for an attenuated mitochondrial adaptive plasticity in aged skeletal muscle. Aging (Albany NY) (2009) 0.86

Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I. Mol Endocrinol (2011) 0.86

SCO2 induces p53-mediated apoptosis by Thr845 phosphorylation of ASK-1 and dissociation of the ASK-1-Trx complex. Mol Cell Biol (2013) 0.86

Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. Am J Pathol (2010) 0.85

Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage. Hum Mol Genet (2013) 0.85

Loss of apoptosis-inducing factor results in cell-type-specific neurogenesis defects. J Neurosci (2008) 0.85

Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradation. Biochemistry (2011) 0.85

Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency. EBioMedicine (2017) 0.84

Mitochondrial cytochrome c oxidase deficiency. Clin Sci (Lond) (2016) 0.84

Mitochondria and apoptosis. Science (1998) 23.41

Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 14.41

The expanding role of mitochondria in apoptosis. Genes Dev (2001) 9.91

Mitochondrial control of cell death. Nat Med (2000) 9.17

Mitochondrial respiratory-chain diseases. N Engl J Med (2003) 8.68

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (2002) 8.41

Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol (1999) 8.21

Endonuclease G is an apoptotic DNase when released from mitochondria. Nature (2001) 6.20

Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature (2001) 5.07

Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta (1994) 4.93

The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature (2002) 3.30

The respiratory chain components of higher plant mitochondria. Plant Physiol (1968) 3.12

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10

Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A (1999) 2.91

Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun (2003) 2.58

The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta (2003) 2.37

Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science (2002) 2.36

An AIF orthologue regulates apoptosis in yeast. J Cell Biol (2004) 2.33

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature (2003) 2.22

NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem (2001) 2.22

Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. Electrophoresis (1997) 2.04

Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol (2003) 1.95

Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol (2002) 1.90

Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci (2002) 1.88

Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest (2003) 1.84

Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J Biol Chem (1998) 1.83

Mitochondria and degenerative disorders. Am J Med Genet (2001) 1.81

DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol (2002) 1.81

Respiratory chain supercomplexes of mitochondria and bacteria. Biochim Biophys Acta (2002) 1.69

Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet (2000) 1.68

AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene (2004) 1.68

Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J (2001) 1.64

Respiratory chain complex I deficiency. Am J Med Genet (2001) 1.42

Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell (2002) 1.41

Nuclear genetic defects of oxidative phosphorylation. Hum Mol Genet (2001) 1.37

Respiration-dependent removal of exogenous H2O2 in brain mitochondria: inhibition by Ca2+. J Biol Chem (2003) 1.32

Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J Cell Sci (2004) 1.29

Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts. Hum Mol Genet (2001) 1.24

Genetic defects of cytochrome c oxidase assembly. Physiol Res (2004) 1.20

Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab (2002) 1.17

Assessment of the mitochondrial respiratory chain. Lancet (1991) 1.16

Development and characterization of a conditional mitochondrial complex I assembly system. J Biol Chem (2004) 1.13

Complex I assembly: a puzzling problem. Curr Opin Neurol (2004) 1.06

Animal models for respiratory chain disease. Trends Mol Med (2001) 1.03

Assay of mitochondrial respiratory chain complex I in human lymphocytes and cultured skin fibroblasts. Biochem Biophys Res Commun (2003) 1.01

Clinical heterogeneity in patients with mutations in the NDUFS4 gene of mitochondrial complex I. J Inherit Metab Dis (2003) 0.99

Revisiting pitfalls, problems and tentative solutions for assaying mitochondrial respiratory chain complex III in human samples. Curr Med Chem (2004) 0.93

The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity. Neurotoxicology (2003) 0.92

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47

The hallmarks of aging. Cell (2013) 14.29

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

The pathophysiology of mitochondrial cell death. Science (2004) 13.87

Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J (2007) 11.72

Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med (2006) 10.54

Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol (2005) 10.27

Cerebral organoids model human brain development and microcephaly. Nature (2013) 9.07

Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol (2010) 9.06

Blue native PAGE. Nat Protoc (2006) 8.04

Ambra1 regulates autophagy and development of the nervous system. Nature (2007) 6.94

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med (2009) 6.73

Immunological aspects of cancer chemotherapy. Nat Rev Immunol (2008) 6.61

Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell (2008) 6.37

Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13

Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov (2006) 5.99

Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97

Autophagy and aging. Cell (2011) 5.96

Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (2011) 5.62

Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27

Cytoplasmic functions of the tumour suppressor p53. Nature (2009) 5.23

Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature (2002) 5.02

Induction of autophagy by spermidine promotes longevity. Nat Cell Biol (2009) 5.00

Mitogen-activated protein kinases in apoptosis regulation. Oncogene (2004) 4.76

Cell death by mitotic catastrophe: a molecular definition. Oncogene (2004) 4.75

Cell death by necrosis: towards a molecular definition. Trends Biochem Sci (2006) 4.67

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60

A caspase-related protease regulates apoptosis in yeast. Mol Cell (2002) 4.43

Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy (2008) 4.42

An immunosurveillance mechanism controls cancer cell ploidy. Science (2012) 4.35

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell (2002) 4.35

Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 4.34

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med (2005) 4.32

The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol (2007) 4.12

Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet (2004) 4.11

Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN. Nature (2006) 4.09

Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature (2010) 4.01

The anticancer immune response: indispensable for therapeutic success? J Clin Invest (2008) 4.01

ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med (2011) 3.96

The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci (2005) 3.93

Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell (2007) 3.82

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature (2002) 3.74

Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (2011) 3.74

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity (2013) 3.73

RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med (2005) 3.68

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med (2005) 3.64

The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov (2012) 3.60

Decoding cell death signals in inflammation and immunity. Cell (2010) 3.41

Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol (2011) 3.41

Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol (2011) 3.40

Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity (2003) 3.36

RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol (2001) 3.27

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med (2005) 3.26

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26

SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell (2013) 3.24

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest (2009) 3.23

Does autophagy contribute to cell death? Autophagy (2005) 3.21

A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med (2006) 3.21

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle (2006) 3.21

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19

Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol (2006) 3.19

The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol (2010) 3.17

Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst (2006) 3.17

Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem (2003) 3.16

Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature (2005) 3.09

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med (2006) 3.09

BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy (2007) 3.08

SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet (2010) 3.07

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med (2011) 3.03

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev (2007) 2.96

FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling. Cell Metab (2012) 2.96

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med (2013) 2.93

RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med (2007) 2.91